Prescribing with precision: A pharmacogenomics primer
Pharmacogenomics, the study of how a person’s genes affect their response to medications, holds great potential – but obstacles to its adoption abound.
Fresh perspectives on clinical terminologies, code mapping, and patient insights from the experts at IMO.
Pharmacogenomics, the study of how a person’s genes affect their response to medications, holds great potential – but obstacles to its adoption abound.
With the easing of COVID-19 restrictions countries are reducing genomic surveillance, limiting the data necessary to prepare for new variants.
Interoperability in healthcare involves layers of technical, syntactic, and semantic data exchange. The latter has proven the most elusive to achieve.
IMO’s CEO, Ann Barnes, reflects on the company’s future in light of IMO’s recent acquisition by THL Partners.
Clinical documentation is a key part of patient care – but it can be taxing on providers. Natural language processing can help. Here’s how.
Investment will support product development and help IMO expand commercial relationships with hospitals and other healthcare providers.
Many health information exchanges struggle to maximize the insights they get from patient records – but normalization can help.
From bright-eyed intern to seasoned sales engineer, Megan Broom talks about her 10-year journey at IMO in the latest installment of In My Opinion.
HCCs are critically important, yet complex and sometimes confusing. We’re highlighting five things to simplify HCC documentation within EHR workflows.
In our latest eBook, we explore the hazards of incomplete and inconsistent data for health systems and how healthcare data normalization can help.
Apps that improve native EHR workflows are making the medical problem list easier to use. And that’s great news for providers and patients alike.
IMO Precision Normalize helps one of the largest HIE networks in the US standardize data from a variety of disparate sources.